Syndax Pharmaceuticals, Inc. - stock earnings
SNDX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -72.5 million USD | 536000 USD |
| 2023Q3 | -51.1 million USD | ? USD |
| 2023Q2 | -44.6 million USD | ? USD |
| 2023Q1 | -36.2 million USD | ? USD |
| 2022Q4 | -36.3 million USD | ? USD |
| 2022Q3 | -35.7 million USD | ? USD |
| 2022Q2 | -37.4 million USD | ? USD |
| 2022Q1 | -37.5 million USD | ? USD |
| 2021Q4 | 96.2 million USD | 126.6 million USD |
| 2021Q3 | -20.6 million USD | 12.4 million USD |
| 2021Q2 | -22.9 million USD | 379000 USD |
| 2021Q1 | -27.7 million USD | 379000 USD |
| 2020Q4 | -20.4 million USD | 380000 USD |
| 2020Q3 | -20.4 million USD | 379000 USD |
| 2020Q2 | -17.1 million USD | 379000 USD |
| 2020Q1 | -15.2 million USD | 379000 USD |
| 2019Q4 | -14.0 million USD | 380000 USD |
| 2019Q3 | -12.8 million USD | 379000 USD |
| 2019Q2 | -14.9 million USD | 379000 USD |
| 2019Q1 | -14.3 million USD | 379000 USD |
| 2018Q4 | -18.8 million USD | 380000 USD |
| 2018Q3 | -17.3 million USD | 379000 USD |
| 2018Q2 | -18.4 million USD | 379000 USD |
| 2018Q1 | -19.4 million USD | 379000 USD |
| 2017Q4 | -19.1 million USD | 1.2 million USD |
| 2017Q3 | -15.1 million USD | 305000 USD |
| 2017Q2 | -13.6 million USD | 305000 USD |
| 2017Q1 | -13.0 million USD | 305000 USD |
| 2016Q4 | -10.8 million USD | 305000 USD |
| 2016Q3 | -15.0 million USD | 305000 USD |
| 2016Q2 | -8.4 million USD | 305000 USD |
| 2016Q1 | -10.3 million USD | 305000 USD |
| 2015Q4 | -5.3 million USD | 305000 USD |
| 2015Q3 | -7.7 million USD | 305000 USD |
| 2015Q2 | -6.2 million USD | 17000 USD |
| 2015Q1 | -4.9 million USD | ? USD |
| 2014Q4 | -3.5 million USD | ? USD |
| 2014Q3 | -7.8 million USD | ? USD |
| 2014Q2 | -4.5 million USD | ? USD |
| 2014Q1 | -4.0 million USD | ? USD |
| 2013Q4 | -4.3 million USD | ? USD |
| 2013Q3 | -4.9 million USD | ? USD |
| 2013Q2 | -3.8 million USD | ? USD |
| 2013Q1 | -1.1 million USD | ? USD |
SNDX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -209.4 million USD | ? USD |
| 2022 | -143.7 million USD | 126.6 million USD |
| 2021 | 24.9 million USD | 139.7 million USD |
| 2020 | -73.1 million USD | 1.5 million USD |
| 2019 | -56.0 million USD | 1.5 million USD |
| 2018 | -74.0 million USD | 1.5 million USD |
| 2017 | -60.8 million USD | 2.1 million USD |
| 2016 | -44.5 million USD | 1.2 million USD |
| 2015 | -24.1 million USD | 627000 USD |
| 2014 | -19.8 million USD | ? USD |
| 2013 | -14.2 million USD | ? USD |
| 2012 | -10.0 million USD | ? USD |
SNDX
Price: $22.50
52 week price:
Earnings Per Share: -2.98 USD
P/E Ratio: -8.53
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 44479
Ebitda: -15.3 millionMarket Capitalization: 1.9 billion